Global Toripalimab Supply, Demand and Key Producers, 2026-2032
The global Toripalimab market size is expected to reach $ 896 million by 2032, rising at a market growth of 13.4% CAGR during the forecast period (2026-2032).
Toripalimab is a humanized IgG4 monoclonal antibody and a programmed cell death protein-1 (PD-1) immune checkpoint inhibitor. It works by binding to the PD-1 receptor on T cells, thereby blocking its interaction with PD-L1 and PD-L2. This mechanism relieves tumor-induced immunosuppression and restores and enhances the body’s anti-tumor immune response. Toripalimab is primarily used in the immunotherapy of various malignancies, such as melanoma, non-small cell lung cancer (NSCLC), and nasopharyngeal carcinoma. It has significant clinical value in the field of cancer immunotherapy.In 2025, global production of toripalimab reached approximately 1.2 million vials.
Toripalimab, as one of the first domestically developed and successfully internationalized PD-1 immune checkpoint inhibitors in China, holds an important position in the cancer immunotherapy market. With the continuous rise in global cancer incidence and the expanding clinical application of immunotherapy across multiple solid tumors, the PD-1 inhibitor market is maintaining rapid growth. Toripalimab has achieved relatively high market penetration in China, supported by a broad range of approved indications, the advancement of reimbursement coverage, and strong clinical performance in tumor types such as nasopharyngeal carcinoma. It is also gradually expanding into overseas markets, including Europe and the United States. From a competitive landscape perspective, the market is dominated by global blockbuster products such as pembrolizumab and nivolumab. However, domestic products demonstrate certain competitive advantages driven by pricing benefits and policy support. Looking ahead, with the approval of additional indications and the expansion of international commercialization, the market size of toripalimab is expected to continue growing, strengthening its position in the global PD-1 inhibitor landscape.
This report studies the global Toripalimab production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Toripalimab and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Toripalimab that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Toripalimab total production and demand, 2021-2032, (Units)
Global Toripalimab total production value, 2021-2032, (USD Million)
Global Toripalimab production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (Units), (based on production site)
Global Toripalimab consumption by region & country, CAGR, 2021-2032 & (Units)
U.S. VS China: Toripalimab domestic production, consumption, key domestic manufacturers and share
Global Toripalimab production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (Units)
Global Toripalimab production by Type, production, value, CAGR, 2021-2032, (USD Million) & (Units)
Global Toripalimab production by Application, production, value, CAGR, 2021-2032, (USD Million) & (Units)
This report profiles key players in the global Toripalimab market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Shanghai Junshi Biosciences, Coherus BioSciences, Apotex, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Toripalimab market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Toripalimab Market, By Region:
1. How big is the global Toripalimab market?
2. What is the demand of the global Toripalimab market?
3. What is the year over year growth of the global Toripalimab market?
4. What is the production and production value of the global Toripalimab market?
5. Who are the key producers in the global Toripalimab market?
6. What are the growth factors driving the market demand?
Toripalimab is a humanized IgG4 monoclonal antibody and a programmed cell death protein-1 (PD-1) immune checkpoint inhibitor. It works by binding to the PD-1 receptor on T cells, thereby blocking its interaction with PD-L1 and PD-L2. This mechanism relieves tumor-induced immunosuppression and restores and enhances the body’s anti-tumor immune response. Toripalimab is primarily used in the immunotherapy of various malignancies, such as melanoma, non-small cell lung cancer (NSCLC), and nasopharyngeal carcinoma. It has significant clinical value in the field of cancer immunotherapy.In 2025, global production of toripalimab reached approximately 1.2 million vials.
Toripalimab, as one of the first domestically developed and successfully internationalized PD-1 immune checkpoint inhibitors in China, holds an important position in the cancer immunotherapy market. With the continuous rise in global cancer incidence and the expanding clinical application of immunotherapy across multiple solid tumors, the PD-1 inhibitor market is maintaining rapid growth. Toripalimab has achieved relatively high market penetration in China, supported by a broad range of approved indications, the advancement of reimbursement coverage, and strong clinical performance in tumor types such as nasopharyngeal carcinoma. It is also gradually expanding into overseas markets, including Europe and the United States. From a competitive landscape perspective, the market is dominated by global blockbuster products such as pembrolizumab and nivolumab. However, domestic products demonstrate certain competitive advantages driven by pricing benefits and policy support. Looking ahead, with the approval of additional indications and the expansion of international commercialization, the market size of toripalimab is expected to continue growing, strengthening its position in the global PD-1 inhibitor landscape.
This report studies the global Toripalimab production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Toripalimab and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Toripalimab that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Toripalimab total production and demand, 2021-2032, (Units)
Global Toripalimab total production value, 2021-2032, (USD Million)
Global Toripalimab production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (Units), (based on production site)
Global Toripalimab consumption by region & country, CAGR, 2021-2032 & (Units)
U.S. VS China: Toripalimab domestic production, consumption, key domestic manufacturers and share
Global Toripalimab production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (Units)
Global Toripalimab production by Type, production, value, CAGR, 2021-2032, (USD Million) & (Units)
Global Toripalimab production by Application, production, value, CAGR, 2021-2032, (USD Million) & (Units)
This report profiles key players in the global Toripalimab market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Shanghai Junshi Biosciences, Coherus BioSciences, Apotex, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Toripalimab market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Toripalimab Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Monoclonal Antibody, mAb
- Bispecific Antibody, BsAb
- 80 mg / 4 mL
- 240 mg / 6 mL
- Innovator
- Generic
- Injection
- Sterile Powder for Injection
- Melanoma
- Non-Small Cell Lung Cancer
- Nasopharyngeal Carcinoma, NPC
- Esophageal Cancer
- Hepatocellular Carcinoma, HCC
- Urothelial Carcinoma
- Others
- Shanghai Junshi Biosciences
- Coherus BioSciences
- Apotex
1. How big is the global Toripalimab market?
2. What is the demand of the global Toripalimab market?
3. What is the year over year growth of the global Toripalimab market?
4. What is the production and production value of the global Toripalimab market?
5. Who are the key producers in the global Toripalimab market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Toripalimab Introduction
1.2 World Toripalimab Supply & Forecast
1.2.1 World Toripalimab Production Value (2021 & 2025 & 2032)
1.2.2 World Toripalimab Production (2021-2032)
1.2.3 World Toripalimab Pricing Trends (2021-2032)
1.3 World Toripalimab Production by Region (Based on Production Site)
1.3.1 World Toripalimab Production Value by Region (2021-2032)
1.3.2 World Toripalimab Production by Region (2021-2032)
1.3.3 World Toripalimab Average Price by Region (2021-2032)
1.3.4 North America Toripalimab Production (2021-2032)
1.3.5 Europe Toripalimab Production (2021-2032)
1.3.6 China Toripalimab Production (2021-2032)
1.3.7 Japan Toripalimab Production (2021-2032)
1.3.8 India Toripalimab Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Toripalimab Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Toripalimab Major Market Trends
2 DEMAND SUMMARY
2.1 World Toripalimab Demand (2021-2032)
2.2 World Toripalimab Consumption by Region
2.2.1 World Toripalimab Consumption by Region (2021-2026)
2.2.2 World Toripalimab Consumption Forecast by Region (2027-2032)
2.3 United States Toripalimab Consumption (2021-2032)
2.4 China Toripalimab Consumption (2021-2032)
2.5 Europe Toripalimab Consumption (2021-2032)
2.6 Japan Toripalimab Consumption (2021-2032)
2.7 South Korea Toripalimab Consumption (2021-2032)
2.8 ASEAN Toripalimab Consumption (2021-2032)
2.9 India Toripalimab Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Toripalimab Production Value by Manufacturer (2021-2026)
3.2 World Toripalimab Production by Manufacturer (2021-2026)
3.3 World Toripalimab Average Price by Manufacturer (2021-2026)
3.4 Toripalimab Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Toripalimab Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Toripalimab in 2025
3.5.3 Global Concentration Ratios (CR8) for Toripalimab in 2025
3.6 Toripalimab Market: Overall Company Footprint Analysis
3.6.1 Toripalimab Market: Region Footprint
3.6.2 Toripalimab Market: Company Product Type Footprint
3.6.3 Toripalimab Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Toripalimab Production Value Comparison
4.1.1 United States VS China: Toripalimab Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: Toripalimab Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Toripalimab Production Comparison
4.2.1 United States VS China: Toripalimab Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Toripalimab Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Toripalimab Consumption Comparison
4.3.1 United States VS China: Toripalimab Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: Toripalimab Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Toripalimab Manufacturers and Market Share, 2021-2026
4.4.1 United States Based Toripalimab Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Toripalimab Production Value (2021-2026)
4.4.3 United States Based Manufacturers Toripalimab Production (2021-2026)
4.5 China Based Toripalimab Manufacturers and Market Share
4.5.1 China Based Toripalimab Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Toripalimab Production Value (2021-2026)
4.5.3 China Based Manufacturers Toripalimab Production (2021-2026)
4.6 Rest of World Based Toripalimab Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based Toripalimab Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Toripalimab Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers Toripalimab Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Toripalimab Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Monoclonal Antibody, mAb
5.2.2 Bispecific Antibody, BsAb
5.3 Market Segment by Type
5.3.1 World Toripalimab Production by Type (2021-2032)
5.3.2 World Toripalimab Production Value by Type (2021-2032)
5.3.3 World Toripalimab Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY SPECIFICATION
6.1 World Toripalimab Market Size Overview by Specification: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Specification
6.2.1 80 mg / 4 mL
6.2.2 240 mg / 6 mL
6.3 Market Segment by Specification
6.3.1 World Toripalimab Production by Specification (2021-2032)
6.3.2 World Toripalimab Production Value by Specification (2021-2032)
6.3.3 World Toripalimab Average Price by Specification (2021-2032)
7 MARKET ANALYSIS BY SALES CHANNELS
7.1 World Toripalimab Market Size Overview by Sales Channels: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Sales Channels
7.2.1 Innovator
7.2.2 Generic
7.3 Market Segment by Sales Channels
7.3.1 World Toripalimab Production by Sales Channels (2021-2032)
7.3.2 World Toripalimab Production Value by Sales Channels (2021-2032)
7.3.3 World Toripalimab Average Price by Sales Channels (2021-2032)
8 MARKET ANALYSIS BY DOSAGE FORM
8.1 World Toripalimab Market Size Overview by Dosage Form: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Dosage Form
8.2.1 Injection
8.2.2 Sterile Powder for Injection
8.3 Market Segment by Dosage Form
8.3.1 World Toripalimab Production by Dosage Form (2021-2032)
8.3.2 World Toripalimab Production Value by Dosage Form (2021-2032)
8.3.3 World Toripalimab Average Price by Dosage Form (2021-2032)
9 MARKET ANALYSIS BY APPLICATION
9.1 World Toripalimab Market Size Overview by Application: 2021 VS 2025 VS 2032
9.2 Segment Introduction by Application
9.2.1 Melanoma
9.2.2 Non-Small Cell Lung Cancer
9.2.3 Nasopharyngeal Carcinoma, NPC
9.2.4 Esophageal Cancer
9.2.5 Hepatocellular Carcinoma, HCC
9.2.6 Urothelial Carcinoma
9.2.7 Others
9.3 Market Segment by Application
9.3.1 World Toripalimab Production by Application (2021-2032)
9.3.2 World Toripalimab Production Value by Application (2021-2032)
9.3.3 World Toripalimab Average Price by Application (2021-2032)
10 COMPANY PROFILES
10.1 Shanghai Junshi Biosciences
10.1.1 Shanghai Junshi Biosciences Details
10.1.2 Shanghai Junshi Biosciences Major Business
10.1.3 Shanghai Junshi Biosciences Toripalimab Product and Services
10.1.4 Shanghai Junshi Biosciences Toripalimab Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.1.5 Shanghai Junshi Biosciences Recent Developments/Updates
10.1.6 Shanghai Junshi Biosciences Competitive Strengths & Weaknesses
10.2 Coherus BioSciences
10.2.1 Coherus BioSciences Details
10.2.2 Coherus BioSciences Major Business
10.2.3 Coherus BioSciences Toripalimab Product and Services
10.2.4 Coherus BioSciences Toripalimab Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.2.5 Coherus BioSciences Recent Developments/Updates
10.2.6 Coherus BioSciences Competitive Strengths & Weaknesses
10.3 Apotex
10.3.1 Apotex Details
10.3.2 Apotex Major Business
10.3.3 Apotex Toripalimab Product and Services
10.3.4 Apotex Toripalimab Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.3.5 Apotex Recent Developments/Updates
10.3.6 Apotex Competitive Strengths & Weaknesses
11 INDUSTRY CHAIN ANALYSIS
11.1 Toripalimab Industry Chain
11.2 Toripalimab Upstream Analysis
11.2.1 Toripalimab Core Raw Materials
11.2.2 Main Manufacturers of Toripalimab Core Raw Materials
11.3 Midstream Analysis
11.4 Downstream Analysis
11.5 Toripalimab Production Mode
11.6 Toripalimab Procurement Model
11.7 Toripalimab Industry Sales Model and Sales Channels
11.7.1 Toripalimab Sales Model
11.7.2 Toripalimab Typical Distributors
12 RESEARCH FINDINGS AND CONCLUSION
13 APPENDIX
13.1 Methodology
13.2 Research Process and Data Source
13.3 Disclaimer
1.1 Toripalimab Introduction
1.2 World Toripalimab Supply & Forecast
1.2.1 World Toripalimab Production Value (2021 & 2025 & 2032)
1.2.2 World Toripalimab Production (2021-2032)
1.2.3 World Toripalimab Pricing Trends (2021-2032)
1.3 World Toripalimab Production by Region (Based on Production Site)
1.3.1 World Toripalimab Production Value by Region (2021-2032)
1.3.2 World Toripalimab Production by Region (2021-2032)
1.3.3 World Toripalimab Average Price by Region (2021-2032)
1.3.4 North America Toripalimab Production (2021-2032)
1.3.5 Europe Toripalimab Production (2021-2032)
1.3.6 China Toripalimab Production (2021-2032)
1.3.7 Japan Toripalimab Production (2021-2032)
1.3.8 India Toripalimab Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Toripalimab Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Toripalimab Major Market Trends
2 DEMAND SUMMARY
2.1 World Toripalimab Demand (2021-2032)
2.2 World Toripalimab Consumption by Region
2.2.1 World Toripalimab Consumption by Region (2021-2026)
2.2.2 World Toripalimab Consumption Forecast by Region (2027-2032)
2.3 United States Toripalimab Consumption (2021-2032)
2.4 China Toripalimab Consumption (2021-2032)
2.5 Europe Toripalimab Consumption (2021-2032)
2.6 Japan Toripalimab Consumption (2021-2032)
2.7 South Korea Toripalimab Consumption (2021-2032)
2.8 ASEAN Toripalimab Consumption (2021-2032)
2.9 India Toripalimab Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Toripalimab Production Value by Manufacturer (2021-2026)
3.2 World Toripalimab Production by Manufacturer (2021-2026)
3.3 World Toripalimab Average Price by Manufacturer (2021-2026)
3.4 Toripalimab Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Toripalimab Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Toripalimab in 2025
3.5.3 Global Concentration Ratios (CR8) for Toripalimab in 2025
3.6 Toripalimab Market: Overall Company Footprint Analysis
3.6.1 Toripalimab Market: Region Footprint
3.6.2 Toripalimab Market: Company Product Type Footprint
3.6.3 Toripalimab Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Toripalimab Production Value Comparison
4.1.1 United States VS China: Toripalimab Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: Toripalimab Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Toripalimab Production Comparison
4.2.1 United States VS China: Toripalimab Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Toripalimab Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Toripalimab Consumption Comparison
4.3.1 United States VS China: Toripalimab Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: Toripalimab Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Toripalimab Manufacturers and Market Share, 2021-2026
4.4.1 United States Based Toripalimab Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Toripalimab Production Value (2021-2026)
4.4.3 United States Based Manufacturers Toripalimab Production (2021-2026)
4.5 China Based Toripalimab Manufacturers and Market Share
4.5.1 China Based Toripalimab Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Toripalimab Production Value (2021-2026)
4.5.3 China Based Manufacturers Toripalimab Production (2021-2026)
4.6 Rest of World Based Toripalimab Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based Toripalimab Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Toripalimab Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers Toripalimab Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Toripalimab Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Monoclonal Antibody, mAb
5.2.2 Bispecific Antibody, BsAb
5.3 Market Segment by Type
5.3.1 World Toripalimab Production by Type (2021-2032)
5.3.2 World Toripalimab Production Value by Type (2021-2032)
5.3.3 World Toripalimab Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY SPECIFICATION
6.1 World Toripalimab Market Size Overview by Specification: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Specification
6.2.1 80 mg / 4 mL
6.2.2 240 mg / 6 mL
6.3 Market Segment by Specification
6.3.1 World Toripalimab Production by Specification (2021-2032)
6.3.2 World Toripalimab Production Value by Specification (2021-2032)
6.3.3 World Toripalimab Average Price by Specification (2021-2032)
7 MARKET ANALYSIS BY SALES CHANNELS
7.1 World Toripalimab Market Size Overview by Sales Channels: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Sales Channels
7.2.1 Innovator
7.2.2 Generic
7.3 Market Segment by Sales Channels
7.3.1 World Toripalimab Production by Sales Channels (2021-2032)
7.3.2 World Toripalimab Production Value by Sales Channels (2021-2032)
7.3.3 World Toripalimab Average Price by Sales Channels (2021-2032)
8 MARKET ANALYSIS BY DOSAGE FORM
8.1 World Toripalimab Market Size Overview by Dosage Form: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Dosage Form
8.2.1 Injection
8.2.2 Sterile Powder for Injection
8.3 Market Segment by Dosage Form
8.3.1 World Toripalimab Production by Dosage Form (2021-2032)
8.3.2 World Toripalimab Production Value by Dosage Form (2021-2032)
8.3.3 World Toripalimab Average Price by Dosage Form (2021-2032)
9 MARKET ANALYSIS BY APPLICATION
9.1 World Toripalimab Market Size Overview by Application: 2021 VS 2025 VS 2032
9.2 Segment Introduction by Application
9.2.1 Melanoma
9.2.2 Non-Small Cell Lung Cancer
9.2.3 Nasopharyngeal Carcinoma, NPC
9.2.4 Esophageal Cancer
9.2.5 Hepatocellular Carcinoma, HCC
9.2.6 Urothelial Carcinoma
9.2.7 Others
9.3 Market Segment by Application
9.3.1 World Toripalimab Production by Application (2021-2032)
9.3.2 World Toripalimab Production Value by Application (2021-2032)
9.3.3 World Toripalimab Average Price by Application (2021-2032)
10 COMPANY PROFILES
10.1 Shanghai Junshi Biosciences
10.1.1 Shanghai Junshi Biosciences Details
10.1.2 Shanghai Junshi Biosciences Major Business
10.1.3 Shanghai Junshi Biosciences Toripalimab Product and Services
10.1.4 Shanghai Junshi Biosciences Toripalimab Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.1.5 Shanghai Junshi Biosciences Recent Developments/Updates
10.1.6 Shanghai Junshi Biosciences Competitive Strengths & Weaknesses
10.2 Coherus BioSciences
10.2.1 Coherus BioSciences Details
10.2.2 Coherus BioSciences Major Business
10.2.3 Coherus BioSciences Toripalimab Product and Services
10.2.4 Coherus BioSciences Toripalimab Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.2.5 Coherus BioSciences Recent Developments/Updates
10.2.6 Coherus BioSciences Competitive Strengths & Weaknesses
10.3 Apotex
10.3.1 Apotex Details
10.3.2 Apotex Major Business
10.3.3 Apotex Toripalimab Product and Services
10.3.4 Apotex Toripalimab Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.3.5 Apotex Recent Developments/Updates
10.3.6 Apotex Competitive Strengths & Weaknesses
11 INDUSTRY CHAIN ANALYSIS
11.1 Toripalimab Industry Chain
11.2 Toripalimab Upstream Analysis
11.2.1 Toripalimab Core Raw Materials
11.2.2 Main Manufacturers of Toripalimab Core Raw Materials
11.3 Midstream Analysis
11.4 Downstream Analysis
11.5 Toripalimab Production Mode
11.6 Toripalimab Procurement Model
11.7 Toripalimab Industry Sales Model and Sales Channels
11.7.1 Toripalimab Sales Model
11.7.2 Toripalimab Typical Distributors
12 RESEARCH FINDINGS AND CONCLUSION
13 APPENDIX
13.1 Methodology
13.2 Research Process and Data Source
13.3 Disclaimer
LIST OF TABLES
Table 1. World Toripalimab Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Toripalimab Production Value by Region (2021-2026) & (USD Million)
Table 3. World Toripalimab Production Value by Region (2027-2032) & (USD Million)
Table 4. World Toripalimab Production Value Market Share by Region (2021-2026)
Table 5. World Toripalimab Production Value Market Share by Region (2027-2032)
Table 6. World Toripalimab Production by Region (2021-2026) & (Units)
Table 7. World Toripalimab Production by Region (2027-2032) & (Units)
Table 8. World Toripalimab Production Market Share by Region (2021-2026)
Table 9. World Toripalimab Production Market Share by Region (2027-2032)
Table 10. World Toripalimab Average Price by Region (2021-2026) & (US$/Unit)
Table 11. World Toripalimab Average Price by Region (2027-2032) & (US$/Unit)
Table 12. Toripalimab Major Market Trends
Table 13. World Toripalimab Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (Units)
Table 14. World Toripalimab Consumption by Region (2021-2026) & (Units)
Table 15. World Toripalimab Consumption Forecast by Region (2027-2032) & (Units)
Table 16. World Toripalimab Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Toripalimab Producers in 2025
Table 18. World Toripalimab Production by Manufacturer (2021-2026) & (Units)
Table 19. Production Market Share of Key Toripalimab Producers in 2025
Table 20. World Toripalimab Average Price by Manufacturer (2021-2026) & (US$/Unit)
Table 21. Global Toripalimab Company Evaluation Quadrant
Table 22. World Toripalimab Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Toripalimab Production Site of Key Manufacturer
Table 24. Toripalimab Market: Company Product Type Footprint
Table 25. Toripalimab Market: Company Product Application Footprint
Table 26. Toripalimab Competitive Factors
Table 27. Toripalimab New Entrant and Capacity Expansion Plans
Table 28. Toripalimab Mergers & Acquisitions Activity
Table 29. United States VS China Toripalimab Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Toripalimab Production Comparison, (2021 & 2025 & 2032) & (Units)
Table 31. United States VS China Toripalimab Consumption Comparison, (2021 & 2025 & 2032) & (Units)
Table 32. United States Based Toripalimab Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Toripalimab Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Toripalimab Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Toripalimab Production (2021-2026) & (Units)
Table 36. United States Based Manufacturers Toripalimab Production Market Share (2021-2026)
Table 37. China Based Toripalimab Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Toripalimab Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Toripalimab Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Toripalimab Production, (2021-2026) & (Units)
Table 41. China Based Manufacturers Toripalimab Production Market Share (2021-2026)
Table 42. Rest of World Based Toripalimab Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Toripalimab Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Toripalimab Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Toripalimab Production, (2021-2026) & (Units)
Table 46. Rest of World Based Manufacturers Toripalimab Production Market Share (2021-2026)
Table 47. World Toripalimab Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World Toripalimab Production by Type (2021-2026) & (Units)
Table 49. World Toripalimab Production by Type (2027-2032) & (Units)
Table 50. World Toripalimab Production Value by Type (2021-2026) & (USD Million)
Table 51. World Toripalimab Production Value by Type (2027-2032) & (USD Million)
Table 52. World Toripalimab Average Price by Type (2021-2026) & (US$/Unit)
Table 53. World Toripalimab Average Price by Type (2027-2032) & (US$/Unit)
Table 54. World Toripalimab Production Value by Specification, (USD Million), 2021 & 2025 & 2032
Table 55. World Toripalimab Production by Specification (2021-2026) & (Units)
Table 56. World Toripalimab Production by Specification (2027-2032) & (Units)
Table 57. World Toripalimab Production Value by Specification (2021-2026) & (USD Million)
Table 58. World Toripalimab Production Value by Specification (2027-2032) & (USD Million)
Table 59. World Toripalimab Average Price by Specification (2021-2026) & (US$/Unit)
Table 60. World Toripalimab Average Price by Specification (2027-2032) & (US$/Unit)
Table 61. World Toripalimab Production Value by Sales Channels, (USD Million), 2021 & 2025 & 2032
Table 62. World Toripalimab Production by Sales Channels (2021-2026) & (Units)
Table 63. World Toripalimab Production by Sales Channels (2027-2032) & (Units)
Table 64. World Toripalimab Production Value by Sales Channels (2021-2026) & (USD Million)
Table 65. World Toripalimab Production Value by Sales Channels (2027-2032) & (USD Million)
Table 66. World Toripalimab Average Price by Sales Channels (2021-2026) & (US$/Unit)
Table 67. World Toripalimab Average Price by Sales Channels (2027-2032) & (US$/Unit)
Table 68. World Toripalimab Production Value by Dosage Form, (USD Million), 2021 & 2025 & 2032
Table 69. World Toripalimab Production by Dosage Form (2021-2026) & (Units)
Table 70. World Toripalimab Production by Dosage Form (2027-2032) & (Units)
Table 71. World Toripalimab Production Value by Dosage Form (2021-2026) & (USD Million)
Table 72. World Toripalimab Production Value by Dosage Form (2027-2032) & (USD Million)
Table 73. World Toripalimab Average Price by Dosage Form (2021-2026) & (US$/Unit)
Table 74. World Toripalimab Average Price by Dosage Form (2027-2032) & (US$/Unit)
Table 75. World Toripalimab Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 76. World Toripalimab Production by Application (2021-2026) & (Units)
Table 77. World Toripalimab Production by Application (2027-2032) & (Units)
Table 78. World Toripalimab Production Value by Application (2021-2026) & (USD Million)
Table 79. World Toripalimab Production Value by Application (2027-2032) & (USD Million)
Table 80. World Toripalimab Average Price by Application (2021-2026) & (US$/Unit)
Table 81. World Toripalimab Average Price by Application (2027-2032) & (US$/Unit)
Table 82. Shanghai Junshi Biosciences Basic Information, Manufacturing Base and Competitors
Table 83. Shanghai Junshi Biosciences Major Business
Table 84. Shanghai Junshi Biosciences Toripalimab Product and Services
Table 85. Shanghai Junshi Biosciences Toripalimab Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 86. Shanghai Junshi Biosciences Recent Developments/Updates
Table 87. Shanghai Junshi Biosciences Competitive Strengths & Weaknesses
Table 88. Coherus BioSciences Basic Information, Manufacturing Base and Competitors
Table 89. Coherus BioSciences Major Business
Table 90. Coherus BioSciences Toripalimab Product and Services
Table 91. Coherus BioSciences Toripalimab Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 92. Coherus BioSciences Recent Developments/Updates
Table 93. Coherus BioSciences Competitive Strengths & Weaknesses
Table 94. Apotex Basic Information, Manufacturing Base and Competitors
Table 95. Apotex Major Business
Table 96. Apotex Toripalimab Product and Services
Table 97. Apotex Toripalimab Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 98. Apotex Recent Developments/Updates
Table 99. Apotex Competitive Strengths & Weaknesses
Table 100. Global Key Players of Toripalimab Upstream (Raw Materials)
Table 101. Global Toripalimab Typical Customers
Table 102. Toripalimab Typical Distributors
Table 1. World Toripalimab Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Toripalimab Production Value by Region (2021-2026) & (USD Million)
Table 3. World Toripalimab Production Value by Region (2027-2032) & (USD Million)
Table 4. World Toripalimab Production Value Market Share by Region (2021-2026)
Table 5. World Toripalimab Production Value Market Share by Region (2027-2032)
Table 6. World Toripalimab Production by Region (2021-2026) & (Units)
Table 7. World Toripalimab Production by Region (2027-2032) & (Units)
Table 8. World Toripalimab Production Market Share by Region (2021-2026)
Table 9. World Toripalimab Production Market Share by Region (2027-2032)
Table 10. World Toripalimab Average Price by Region (2021-2026) & (US$/Unit)
Table 11. World Toripalimab Average Price by Region (2027-2032) & (US$/Unit)
Table 12. Toripalimab Major Market Trends
Table 13. World Toripalimab Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (Units)
Table 14. World Toripalimab Consumption by Region (2021-2026) & (Units)
Table 15. World Toripalimab Consumption Forecast by Region (2027-2032) & (Units)
Table 16. World Toripalimab Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Toripalimab Producers in 2025
Table 18. World Toripalimab Production by Manufacturer (2021-2026) & (Units)
Table 19. Production Market Share of Key Toripalimab Producers in 2025
Table 20. World Toripalimab Average Price by Manufacturer (2021-2026) & (US$/Unit)
Table 21. Global Toripalimab Company Evaluation Quadrant
Table 22. World Toripalimab Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Toripalimab Production Site of Key Manufacturer
Table 24. Toripalimab Market: Company Product Type Footprint
Table 25. Toripalimab Market: Company Product Application Footprint
Table 26. Toripalimab Competitive Factors
Table 27. Toripalimab New Entrant and Capacity Expansion Plans
Table 28. Toripalimab Mergers & Acquisitions Activity
Table 29. United States VS China Toripalimab Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Toripalimab Production Comparison, (2021 & 2025 & 2032) & (Units)
Table 31. United States VS China Toripalimab Consumption Comparison, (2021 & 2025 & 2032) & (Units)
Table 32. United States Based Toripalimab Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Toripalimab Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Toripalimab Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Toripalimab Production (2021-2026) & (Units)
Table 36. United States Based Manufacturers Toripalimab Production Market Share (2021-2026)
Table 37. China Based Toripalimab Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Toripalimab Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Toripalimab Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Toripalimab Production, (2021-2026) & (Units)
Table 41. China Based Manufacturers Toripalimab Production Market Share (2021-2026)
Table 42. Rest of World Based Toripalimab Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Toripalimab Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Toripalimab Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Toripalimab Production, (2021-2026) & (Units)
Table 46. Rest of World Based Manufacturers Toripalimab Production Market Share (2021-2026)
Table 47. World Toripalimab Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World Toripalimab Production by Type (2021-2026) & (Units)
Table 49. World Toripalimab Production by Type (2027-2032) & (Units)
Table 50. World Toripalimab Production Value by Type (2021-2026) & (USD Million)
Table 51. World Toripalimab Production Value by Type (2027-2032) & (USD Million)
Table 52. World Toripalimab Average Price by Type (2021-2026) & (US$/Unit)
Table 53. World Toripalimab Average Price by Type (2027-2032) & (US$/Unit)
Table 54. World Toripalimab Production Value by Specification, (USD Million), 2021 & 2025 & 2032
Table 55. World Toripalimab Production by Specification (2021-2026) & (Units)
Table 56. World Toripalimab Production by Specification (2027-2032) & (Units)
Table 57. World Toripalimab Production Value by Specification (2021-2026) & (USD Million)
Table 58. World Toripalimab Production Value by Specification (2027-2032) & (USD Million)
Table 59. World Toripalimab Average Price by Specification (2021-2026) & (US$/Unit)
Table 60. World Toripalimab Average Price by Specification (2027-2032) & (US$/Unit)
Table 61. World Toripalimab Production Value by Sales Channels, (USD Million), 2021 & 2025 & 2032
Table 62. World Toripalimab Production by Sales Channels (2021-2026) & (Units)
Table 63. World Toripalimab Production by Sales Channels (2027-2032) & (Units)
Table 64. World Toripalimab Production Value by Sales Channels (2021-2026) & (USD Million)
Table 65. World Toripalimab Production Value by Sales Channels (2027-2032) & (USD Million)
Table 66. World Toripalimab Average Price by Sales Channels (2021-2026) & (US$/Unit)
Table 67. World Toripalimab Average Price by Sales Channels (2027-2032) & (US$/Unit)
Table 68. World Toripalimab Production Value by Dosage Form, (USD Million), 2021 & 2025 & 2032
Table 69. World Toripalimab Production by Dosage Form (2021-2026) & (Units)
Table 70. World Toripalimab Production by Dosage Form (2027-2032) & (Units)
Table 71. World Toripalimab Production Value by Dosage Form (2021-2026) & (USD Million)
Table 72. World Toripalimab Production Value by Dosage Form (2027-2032) & (USD Million)
Table 73. World Toripalimab Average Price by Dosage Form (2021-2026) & (US$/Unit)
Table 74. World Toripalimab Average Price by Dosage Form (2027-2032) & (US$/Unit)
Table 75. World Toripalimab Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 76. World Toripalimab Production by Application (2021-2026) & (Units)
Table 77. World Toripalimab Production by Application (2027-2032) & (Units)
Table 78. World Toripalimab Production Value by Application (2021-2026) & (USD Million)
Table 79. World Toripalimab Production Value by Application (2027-2032) & (USD Million)
Table 80. World Toripalimab Average Price by Application (2021-2026) & (US$/Unit)
Table 81. World Toripalimab Average Price by Application (2027-2032) & (US$/Unit)
Table 82. Shanghai Junshi Biosciences Basic Information, Manufacturing Base and Competitors
Table 83. Shanghai Junshi Biosciences Major Business
Table 84. Shanghai Junshi Biosciences Toripalimab Product and Services
Table 85. Shanghai Junshi Biosciences Toripalimab Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 86. Shanghai Junshi Biosciences Recent Developments/Updates
Table 87. Shanghai Junshi Biosciences Competitive Strengths & Weaknesses
Table 88. Coherus BioSciences Basic Information, Manufacturing Base and Competitors
Table 89. Coherus BioSciences Major Business
Table 90. Coherus BioSciences Toripalimab Product and Services
Table 91. Coherus BioSciences Toripalimab Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 92. Coherus BioSciences Recent Developments/Updates
Table 93. Coherus BioSciences Competitive Strengths & Weaknesses
Table 94. Apotex Basic Information, Manufacturing Base and Competitors
Table 95. Apotex Major Business
Table 96. Apotex Toripalimab Product and Services
Table 97. Apotex Toripalimab Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 98. Apotex Recent Developments/Updates
Table 99. Apotex Competitive Strengths & Weaknesses
Table 100. Global Key Players of Toripalimab Upstream (Raw Materials)
Table 101. Global Toripalimab Typical Customers
Table 102. Toripalimab Typical Distributors
LIST OF FIGURES
Figure 1. Toripalimab Picture
Figure 2. World Toripalimab Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Toripalimab Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Toripalimab Production (2021-2032) & (Units)
Figure 5. World Toripalimab Average Price (2021-2032) & (US$/Unit)
Figure 6. World Toripalimab Production Value Market Share by Region (2021-2032)
Figure 7. World Toripalimab Production Market Share by Region (2021-2032)
Figure 8. North America Toripalimab Production (2021-2032) & (Units)
Figure 9. Europe Toripalimab Production (2021-2032) & (Units)
Figure 10. China Toripalimab Production (2021-2032) & (Units)
Figure 11. Japan Toripalimab Production (2021-2032) & (Units)
Figure 12. India Toripalimab Production (2021-2032) & (Units)
Figure 13. Toripalimab Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Toripalimab Consumption (2021-2032) & (Units)
Figure 16. World Toripalimab Consumption Market Share by Region (2021-2032)
Figure 17. United States Toripalimab Consumption (2021-2032) & (Units)
Figure 18. China Toripalimab Consumption (2021-2032) & (Units)
Figure 19. Europe Toripalimab Consumption (2021-2032) & (Units)
Figure 20. Japan Toripalimab Consumption (2021-2032) & (Units)
Figure 21. South Korea Toripalimab Consumption (2021-2032) & (Units)
Figure 22. ASEAN Toripalimab Consumption (2021-2032) & (Units)
Figure 23. India Toripalimab Consumption (2021-2032) & (Units)
Figure 24. Producer Shipments of Toripalimab by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Toripalimab Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Toripalimab Markets in 2025
Figure 27. United States VS China: Toripalimab Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Toripalimab Production Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States VS China: Toripalimab Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 30. United States Based Manufacturers Toripalimab Production Market Share 2025
Figure 31. China Based Manufacturers Toripalimab Production Market Share 2025
Figure 32. Rest of World Based Manufacturers Toripalimab Production Market Share 2025
Figure 33. World Toripalimab Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 34. World Toripalimab Production Value Market Share by Type in 2025
Figure 35. Monoclonal Antibody, mAb
Figure 36. Bispecific Antibody, BsAb
Figure 37. World Toripalimab Production Market Share by Type (2021-2032)
Figure 38. World Toripalimab Production Value Market Share by Type (2021-2032)
Figure 39. World Toripalimab Average Price by Type (2021-2032) & (US$/Unit)
Figure 40. World Toripalimab Production Value by Specification, (USD Million), 2021 & 2025 & 2032
Figure 41. World Toripalimab Production Value Market Share by Specification in 2025
Figure 42. 80 mg / 4 mL
Figure 43. 240 mg / 6 mL
Figure 44. World Toripalimab Production Market Share by Specification (2021-2032)
Figure 45. World Toripalimab Production Value Market Share by Specification (2021-2032)
Figure 46. World Toripalimab Average Price by Specification (2021-2032) & (US$/Unit)
Figure 47. World Toripalimab Production Value by Sales Channels, (USD Million), 2021 & 2025 & 2032
Figure 48. World Toripalimab Production Value Market Share by Sales Channels in 2025
Figure 49. Innovator
Figure 50. Generic
Figure 51. World Toripalimab Production Market Share by Sales Channels (2021-2032)
Figure 52. World Toripalimab Production Value Market Share by Sales Channels (2021-2032)
Figure 53. World Toripalimab Average Price by Sales Channels (2021-2032) & (US$/Unit)
Figure 54. World Toripalimab Production Value by Dosage Form, (USD Million), 2021 & 2025 & 2032
Figure 55. World Toripalimab Production Value Market Share by Dosage Form in 2025
Figure 56. Injection
Figure 57. Sterile Powder for Injection
Figure 58. World Toripalimab Production Market Share by Dosage Form (2021-2032)
Figure 59. World Toripalimab Production Value Market Share by Dosage Form (2021-2032)
Figure 60. World Toripalimab Average Price by Dosage Form (2021-2032) & (US$/Unit)
Figure 61. World Toripalimab Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 62. World Toripalimab Production Value Market Share by Application in 2025
Figure 63. Melanoma
Figure 64. Non-Small Cell Lung Cancer
Figure 65. Nasopharyngeal Carcinoma, NPC
Figure 66. Esophageal Cancer
Figure 67. Hepatocellular Carcinoma, HCC
Figure 68. Urothelial Carcinoma
Figure 69. Others
Figure 70. World Toripalimab Production Market Share by Application (2021-2032)
Figure 71. World Toripalimab Production Value Market Share by Application (2021-2032)
Figure 72. World Toripalimab Average Price by Application (2021-2032) & (US$/Unit)
Figure 73. Toripalimab Industry Chain
Figure 74. Toripalimab Procurement Model
Figure 75. Toripalimab Sales Model
Figure 76. Toripalimab Sales Channels, Direct Sales, and Distribution
Figure 77. Methodology
Figure 78. Research Process and Data Source
Figure 1. Toripalimab Picture
Figure 2. World Toripalimab Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Toripalimab Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Toripalimab Production (2021-2032) & (Units)
Figure 5. World Toripalimab Average Price (2021-2032) & (US$/Unit)
Figure 6. World Toripalimab Production Value Market Share by Region (2021-2032)
Figure 7. World Toripalimab Production Market Share by Region (2021-2032)
Figure 8. North America Toripalimab Production (2021-2032) & (Units)
Figure 9. Europe Toripalimab Production (2021-2032) & (Units)
Figure 10. China Toripalimab Production (2021-2032) & (Units)
Figure 11. Japan Toripalimab Production (2021-2032) & (Units)
Figure 12. India Toripalimab Production (2021-2032) & (Units)
Figure 13. Toripalimab Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Toripalimab Consumption (2021-2032) & (Units)
Figure 16. World Toripalimab Consumption Market Share by Region (2021-2032)
Figure 17. United States Toripalimab Consumption (2021-2032) & (Units)
Figure 18. China Toripalimab Consumption (2021-2032) & (Units)
Figure 19. Europe Toripalimab Consumption (2021-2032) & (Units)
Figure 20. Japan Toripalimab Consumption (2021-2032) & (Units)
Figure 21. South Korea Toripalimab Consumption (2021-2032) & (Units)
Figure 22. ASEAN Toripalimab Consumption (2021-2032) & (Units)
Figure 23. India Toripalimab Consumption (2021-2032) & (Units)
Figure 24. Producer Shipments of Toripalimab by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Toripalimab Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Toripalimab Markets in 2025
Figure 27. United States VS China: Toripalimab Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Toripalimab Production Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States VS China: Toripalimab Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 30. United States Based Manufacturers Toripalimab Production Market Share 2025
Figure 31. China Based Manufacturers Toripalimab Production Market Share 2025
Figure 32. Rest of World Based Manufacturers Toripalimab Production Market Share 2025
Figure 33. World Toripalimab Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 34. World Toripalimab Production Value Market Share by Type in 2025
Figure 35. Monoclonal Antibody, mAb
Figure 36. Bispecific Antibody, BsAb
Figure 37. World Toripalimab Production Market Share by Type (2021-2032)
Figure 38. World Toripalimab Production Value Market Share by Type (2021-2032)
Figure 39. World Toripalimab Average Price by Type (2021-2032) & (US$/Unit)
Figure 40. World Toripalimab Production Value by Specification, (USD Million), 2021 & 2025 & 2032
Figure 41. World Toripalimab Production Value Market Share by Specification in 2025
Figure 42. 80 mg / 4 mL
Figure 43. 240 mg / 6 mL
Figure 44. World Toripalimab Production Market Share by Specification (2021-2032)
Figure 45. World Toripalimab Production Value Market Share by Specification (2021-2032)
Figure 46. World Toripalimab Average Price by Specification (2021-2032) & (US$/Unit)
Figure 47. World Toripalimab Production Value by Sales Channels, (USD Million), 2021 & 2025 & 2032
Figure 48. World Toripalimab Production Value Market Share by Sales Channels in 2025
Figure 49. Innovator
Figure 50. Generic
Figure 51. World Toripalimab Production Market Share by Sales Channels (2021-2032)
Figure 52. World Toripalimab Production Value Market Share by Sales Channels (2021-2032)
Figure 53. World Toripalimab Average Price by Sales Channels (2021-2032) & (US$/Unit)
Figure 54. World Toripalimab Production Value by Dosage Form, (USD Million), 2021 & 2025 & 2032
Figure 55. World Toripalimab Production Value Market Share by Dosage Form in 2025
Figure 56. Injection
Figure 57. Sterile Powder for Injection
Figure 58. World Toripalimab Production Market Share by Dosage Form (2021-2032)
Figure 59. World Toripalimab Production Value Market Share by Dosage Form (2021-2032)
Figure 60. World Toripalimab Average Price by Dosage Form (2021-2032) & (US$/Unit)
Figure 61. World Toripalimab Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 62. World Toripalimab Production Value Market Share by Application in 2025
Figure 63. Melanoma
Figure 64. Non-Small Cell Lung Cancer
Figure 65. Nasopharyngeal Carcinoma, NPC
Figure 66. Esophageal Cancer
Figure 67. Hepatocellular Carcinoma, HCC
Figure 68. Urothelial Carcinoma
Figure 69. Others
Figure 70. World Toripalimab Production Market Share by Application (2021-2032)
Figure 71. World Toripalimab Production Value Market Share by Application (2021-2032)
Figure 72. World Toripalimab Average Price by Application (2021-2032) & (US$/Unit)
Figure 73. Toripalimab Industry Chain
Figure 74. Toripalimab Procurement Model
Figure 75. Toripalimab Sales Model
Figure 76. Toripalimab Sales Channels, Direct Sales, and Distribution
Figure 77. Methodology
Figure 78. Research Process and Data Source
